Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) EBITDA (2016 - 2025)

Historic EBITDA for CV Sciences (CVSI) over the last 14 years, with Q3 2025 value amounting to -$275000.0.

  • CV Sciences' EBITDA rose 1935.48% to -$275000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 million, marking a year-over-year increase of 5721.33%. This contributed to the annual value of -$2.2 million for FY2024, which is 16517.86% down from last year.
  • Latest data reveals that CV Sciences reported EBITDA of -$275000.0 as of Q3 2025, which was up 1935.48% from -$131000.0 recorded in Q2 2025.
  • Over the past 5 years, CV Sciences' EBITDA peaked at $5.8 million during Q1 2023, and registered a low of -$8.8 million during Q4 2021.
  • Over the past 5 years, CV Sciences' median EBITDA value was -$889000.0 (recorded in 2023), while the average stood at -$1.3 million.
  • Per our database at Business Quant, CV Sciences' EBITDA skyrocketed by 48033.0% in 2023 and then plummeted by 11076.02% in 2024.
  • Over the past 5 years, CV Sciences' EBITDA (Quarter) stood at -$8.8 million in 2021, then skyrocketed by 75.97% to -$2.1 million in 2022, then skyrocketed by 58.16% to -$889000.0 in 2023, then grew by 27.33% to -$646000.0 in 2024, then soared by 57.43% to -$275000.0 in 2025.
  • Its EBITDA stands at -$275000.0 for Q3 2025, versus -$131000.0 for Q2 2025 and $11000.0 for Q1 2025.